The Europe Carrier Screening Market would witness market growth of 12.95% CAGR during the forecast period (2021-2027).
The carrier screening market would witness lucrative growth opportunities due to the rise in importance of early disease detection and prevention, increasing demand for personalized medicine, and rising applications of screening tests in genetic disorders, which would open new growth avenues for the overall carrier screening market during the forecast period.
The increasing popularity of smart healthcare procedures is driving the growth of the carrier screening market. In addition, the growing cases of many genetic diseases and other diseases that occur due to the errors in genetic codes in various nations of this region will also contribute to the increasing demand for carrier screening in the region. The population across this region is more aware of maintaining a healthy lifestyle along with getting a regular checkup, for which they are highly adopting procedures that can detect the abnormalities in their genes in order to prevent themselves from any disease in the future.
Due to carrier screening procedures, the individuals get to know about the defects in their genetic codes, thereby creating awareness regarding different diseases related to genes. All such factors are collaboratively working to boost the demand and growth for the carrier screening market in the regional market.
Based on Technology, the market is segmented into DNA Sequencing, Microarrays, Polymerase Chain Reaction and Other technology. Based on End user, the market is segmented into Hospital and Clinics, Physician Offices, Reference Laboratories and Other End Users. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The End-user segment is likely to showcase a similar kind of trend even during the forecast period. Factors such as the growing occurrence of genetic disorders and developments in carrier screening are likely to propel the growth of this segment.
The Germany market dominated the Europe Carrier Screening Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $149.2 million by 2027. The UK market is would experience a CAGR of 9.9% during (2021 - 2027). Additionally, The France market is exhibiting a CAGR of 12.4% during (2021 - 2027).
Free Valuable Insights: The Global Carrier Screening Market Size will Hit $2,501.94 Million by 2027, at a CAGR of 10.81%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Quest Diagnostics, Incorporated, Thermo Fisher Scientific, Illumina, Inc., Eurofins Scientific Group, Invitae Corporation, OPKO Health, Inc., Fulgent Genetics, Sema4 OpCo, Inc., Myriad Genetics, Inc., and Natera, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Expanded Carrier Screening and
- Targeted Disease Carrier Screening
By Technology
- DNA Sequencing
- Microarrays
- Polymerase Chain Reaction and
- Other technology
By End User
- Hospital and Clinics
- Physician Offices
- Reference Laboratories and
- Other End Users
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Quest Diagnostics, Incorporated
- Thermo Fisher Scientific
- Illumina, Inc.
- Eurofins Scientific Group
- Invitae Corporation
- OPKO Health, Inc.
- Fulgent Genetics
- Sema4 OpCo, Inc.
- Myriad Genetics, Inc.
- Natera, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Carrier Screening Market, by Type
1.4.2 Europe Carrier Screening Market, by Technology
1.4.3 Europe Carrier Screening Market, by End User
1.4.4 Europe Carrier Screening Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2017, Jun – 2021, Jun) Leading Players
Chapter 4. Europe Carrier Screening Market by Type
4.1 Europe Expanded Carrier Screening Market by Country
4.2 Europe Targeted Disease Carrier Screening Market by Country
Chapter 5. Europe Carrier Screening Market by Technology
5.1 Europe DNA Sequencing Market by Country
5.2 Europe Microarrays Market by Country
5.3 Europe Polymerase Chain Reaction Market by Country
5.4 Europe Other Technologies Market by Country
Chapter 6. Europe Carrier Screening Market by End user
6.1 Europe Hospital and Clinics Market by Country
6.2 Europe Physician Offices Market by Country
6.3 Europe Reference Laboratories Market by Country
6.4 Europe Other End user Market by Country
Chapter 7. Europe Carrier Screening Market by Country
7.1 Germany Carrier Screening Market
7.1.1 Germany Carrier Screening Market by Type
7.1.2 Germany Carrier Screening Market by Technology
7.1.3 Germany Carrier Screening Market by End user
7.2 UK Carrier Screening Market
7.2.1 UK Carrier Screening Market by Type
7.2.2 UK Carrier Screening Market by Technology
7.2.3 UK Carrier Screening Market by End user
7.3 France Carrier Screening Market
7.3.1 France Carrier Screening Market by Type
7.3.2 France Carrier Screening Market by Technology
7.3.3 France Carrier Screening Market by End user
7.4 Russia Carrier Screening Market
7.4.1 Russia Carrier Screening Market by Type
7.4.2 Russia Carrier Screening Market by Technology
7.4.3 Russia Carrier Screening Market by End user
7.5 Spain Carrier Screening Market
7.5.1 Spain Carrier Screening Market by Type
7.5.2 Spain Carrier Screening Market by Technology
7.5.3 Spain Carrier Screening Market by End user
7.6 Italy Carrier Screening Market
7.6.1 Italy Carrier Screening Market by Type
7.6.2 Italy Carrier Screening Market by Technology
7.6.3 Italy Carrier Screening Market by End user
7.7 Rest of Europe Carrier Screening Market
7.7.1 Rest of Europe Carrier Screening Market by Type
7.7.2 Rest of Europe Carrier Screening Market by Technology
7.7.3 Rest of Europe Carrier Screening Market by End user
Chapter 8. Company Profiles
8.1 Quest Diagnostics, Incorporated
8.1.1 Company Overview
8.1.1 Financial Analysis
8.1.2 Recent strategies and developments:
8.1.2.1 Partnerships, Collaborations, and Agreements:
8.1.2.2 Product Launches and Product Expansions:
8.1.2.3 Acquisition and Mergers:
8.2 Thermo Fisher Scientific, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 Illumina, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.4 Eurofins Scientific Group
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Recent strategies and developments:
8.4.4.1 Partnerships, Collaborations, and Agreements:
8.4.4.2 Acquisition and Mergers:
8.5 Invitae Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.5.5.2 Acquisition and Mergers:
8.6 OPKO Health, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Acquisition and Mergers:
8.7 Fulgent Genetics
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Acquisition and Mergers:
8.8 Sema4 OpCo, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Product Launches and Product Expansions:
8.9 Myriad Genetics, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.5.2 Product Launches and Product Expansions:
8.1 Natera Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.5.2 Product Launches and Product Expansions:
TABLE 1 Europe Carrier Screening Market, 2017 - 2020, USD Million
TABLE 2 Europe Carrier Screening Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Carrier Screening Market
TABLE 4 Product Launches And Product Expansions– Carrier Screening Market
TABLE 5 Acquisition and Mergers– Carrier Screening Market
TABLE 6 Europe Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 7 Europe Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 8 Europe Expanded Carrier Screening Market by Country, 2017 - 2020, USD Million
TABLE 9 Europe Expanded Carrier Screening Market by Country, 2021 - 2027, USD Million
TABLE 10 Europe Targeted Disease Carrier Screening Market by Country, 2017 - 2020, USD Million
TABLE 11 Europe Targeted Disease Carrier Screening Market by Country, 2021 - 2027, USD Million
TABLE 12 Europe Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 13 Europe Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 14 Europe DNA Sequencing Market by Country, 2017 - 2020, USD Million
TABLE 15 Europe DNA Sequencing Market by Country, 2021 - 2027, USD Million
TABLE 16 Europe Microarrays Market by Country, 2017 - 2020, USD Million
TABLE 17 Europe Microarrays Market by Country, 2021 - 2027, USD Million
TABLE 18 Europe Polymerase Chain Reaction Market by Country, 2017 - 2020, USD Million
TABLE 19 Europe Polymerase Chain Reaction Market by Country, 2021 - 2027, USD Million
TABLE 20 Europe Other Technologies Market by Country, 2017 - 2020, USD Million
TABLE 21 Europe Other Technologies Market by Country, 2021 - 2027, USD Million
TABLE 22 Europe Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 23 Europe Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 24 Europe Hospital and Clinics Market by Country, 2017 - 2020, USD Million
TABLE 25 Europe Hospital and Clinics Market by Country, 2021 - 2027, USD Million
TABLE 26 Europe Physician Offices Market by Country, 2017 - 2020, USD Million
TABLE 27 Europe Physician Offices Market by Country, 2021 - 2027, USD Million
TABLE 28 Europe Reference Laboratories Market by Country, 2017 - 2020, USD Million
TABLE 29 Europe Reference Laboratories Market by Country, 2021 - 2027, USD Million
TABLE 30 Europe Other End user Market by Country, 2017 - 2020, USD Million
TABLE 31 Europe Other End user Market by Country, 2021 - 2027, USD Million
TABLE 32 Europe Carrier Screening Market by Country, 2017 - 2020, USD Million
TABLE 33 Europe Carrier Screening Market by Country, 2021 - 2027, USD Million
TABLE 34 Germany Carrier Screening Market, 2017 - 2020, USD Million
TABLE 35 Germany Carrier Screening Market, 2021 - 2027, USD Million
TABLE 36 Germany Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 37 Germany Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 38 Germany Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 39 Germany Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 40 Germany Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 41 Germany Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 42 UK Carrier Screening Market, 2017 - 2020, USD Million
TABLE 43 UK Carrier Screening Market, 2021 - 2027, USD Million
TABLE 44 UK Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 45 UK Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 46 UK Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 47 UK Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 48 UK Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 49 UK Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 50 France Carrier Screening Market, 2017 - 2020, USD Million
TABLE 51 France Carrier Screening Market, 2021 - 2027, USD Million
TABLE 52 France Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 53 France Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 54 France Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 55 France Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 56 France Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 57 France Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 58 Russia Carrier Screening Market, 2017 - 2020, USD Million
TABLE 59 Russia Carrier Screening Market, 2021 - 2027, USD Million
TABLE 60 Russia Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 61 Russia Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 62 Russia Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 63 Russia Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 64 Russia Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 65 Russia Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 66 Spain Carrier Screening Market, 2017 - 2020, USD Million
TABLE 67 Spain Carrier Screening Market, 2021 - 2027, USD Million
TABLE 68 Spain Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 69 Spain Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 70 Spain Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 71 Spain Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 72 Spain Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 73 Spain Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 74 Italy Carrier Screening Market, 2017 - 2020, USD Million
TABLE 75 Italy Carrier Screening Market, 2021 - 2027, USD Million
TABLE 76 Italy Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 77 Italy Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 78 Italy Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 79 Italy Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 80 Italy Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 81 Italy Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 82 Rest of Europe Carrier Screening Market, 2017 - 2020, USD Million
TABLE 83 Rest of Europe Carrier Screening Market, 2021 - 2027, USD Million
TABLE 84 Rest of Europe Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 85 Rest of Europe Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 86 Rest of Europe Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 87 Rest of Europe Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 88 Rest of Europe Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 89 Rest of Europe Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 90 Key Information – Quest Diagnostics, Incorporated
TABLE 91 Key Information – Thermo Fisher Scientific, Inc.
TABLE 92 key information – Illumina, Inc.
TABLE 93 Key Information – Eurofins Scientific Group
TABLE 94 Key Information – Invitae Corporation
TABLE 95 Key Information – OPKO Health, Inc.
TABLE 96 Key Information – Fulgent Genetics
TABLE 97 Key Information – Sema4 OpCo, Inc.
TABLE 98 Key Information – Myriad Genetics, Inc.
TABLE 99 Key Information – Natera Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Product Launches and Product Expansions : 2017, Jun – 2021, Jun) Leading Players
FIG 5 Recent strategies and developments: Quest Diagnostics
FIG 6 Swot analysis: thermo fisher scientific, inc.
FIG 7 Recent strategies and developments: Sema4 OpCo, Inc.